Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
33 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Cliniques universitaires Saint-Luc from Sint-Lambrechts-Woluwe, company number BE0416885016, closed financial year 2025 with a result of € -36.6 million after tax. For that financial year Cliniques universitaires Saint-Luc recorded revenue of € 857.9 million and equity of € 157.5 million. Compared with financial year 2024, the result moved from € 1.4 million to € -36.6 million. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 157.5 million
▼ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -36.6 million
▼ still € 1.4 million profit in 2024
Profit after tax over the fiscal year.
€ 8.4 million
▲ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
4,931.8
▲ 61.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 480.3 million
▲ 4% vs 2024
€ 97,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 26.4 million
▲ 6% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 174.6 million
▲ 49% vs 2024
€ 21.7 million is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 111.5 million
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 93 days on average.
€ 102.4 million
▼ 13% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 705,070,378 | € 758,878,109 | € 813,400,060 | € 857,935,946 | ▲ 5% |
| Profit after taxes | € -1,496,156 | € 9,184,333 | € 1,413,271 | € -36,647,075 | ▼ € 38.1 million |
| Equity | € 201,240,729 | € 194,671,636 | € 195,429,781 | € 157,496,575 | ▼ 19% |
| Total debts | € 342,150,300 | € 364,565,999 | € 365,891,335 | € 419,370,184 | ▲ 15% |
| Cash | € 1,585,686 | € 2,133,613 | € 5,141,657 | € 8,414,260 | ▲ 64% |
| Land & buildings | € 160,756,437 | € 154,823,986 | € 147,907,311 | € 113,949,937 | ▼ 23% |
| Retained profit | € 166,173,743 | € 175,358,076 | € 176,771,347 | € 140,124,272 | ▼ 21% |
| Bank debt | € 142,312,181 | € 163,673,760 | € 117,260,583 | € 174,620,996 | ▲ 49% |
| Balance sheet total | € 591,934,824 | € 591,024,538 | € 593,672,800 | € 612,114,796 | ▲ 3% |
| Employees (FTE) | 4,815.3 | 4,852.1 | 4,870.2 | 4,931.8 | ▲ 61.6 |
Key figures of Cliniques universitaires Saint-Luc, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Cliniques universitaires Saint-Luc?
What happened at Cliniques universitaires Saint-Luc in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Guillaume de Posch stepped down as director. NBB
- Isabelle Leclercq stepped down as director. NBB
- Sophie Servaty stepped down as director. NBB
- Françoise Smets stepped down as director. NBB
- Brieuc de Meeûs d'Argenteuil stepped down as director. NBB
- Vincent Simonart stepped down as director. NBB
- Catherine Hubert stepped down as director. NBB
- Philippe Leroy stepped down as director. NBB
In short
From € 1.5 million loss in 2022 to € 36.6 million loss in 2025.
Best year ever: 2023, with € 9.2 million profit.
Pays suppliers within 93 days on average.
A new publication or filing at Cliniques universitaires Saint-Luc? We notify you, reason included.
Follow Cliniques universitaires Saint-LucDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 25% of Betaplus Pharma itself.
Directors
According to the 2025 annual accounts
since 2020 · until 2026
since 2024 · until 2029
Vincent Simonart
Director
since 2019 · until 2029
Guillaume de Posch
Director
since 2025 · until 2030
Isabelle Leclercq
Director
Also active at: INESU-IMMO, de Duve Institute, CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR, Fondation Saint - Luc, LES VIVIERS SANTE, UCLouvain Patrimoine, GRAND HOPITAL DE CHARLEROI
since 2024 · until 2030
Catherine Hubert
Director
since 2023 · until 2029
Leïla Belkhir
Director
since 2022 · until 2028
Philippe Leroy
Director
Also active at: CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMUR, H.uni, Fondation Saint - Luc, LES VIVIERS SANTE, UCLouvain Patrimoine, GRAND HOPITAL DE CHARLEROI
since 2024 · until 2029
since 2019 · until 2030
Pascale Cornette
Director
since 2022 · until 2027
since 2024 · until 2029
Françoise Smets
Director
Also active at: SOPARTEC, INESU-IMMO, Fondation médicale E. Horlait-Dapsens - Medische Stichting Mathilde E. Horlait-Dapsen, de Duve Institute, AULA MAGNA Louvain-la-Neuve, UCLouvain Patrimoine
since 2024 · until 2030
Nicolas Boël
Director
Also active at: Les Instituts Internationaux de Physique et de Chimie Fondes Par Ernestsolvay, DOMANOY, UBIDATA
since 2022 · until 2027
since 2024 · until 2029
Philippe Dehaspe
Director
Also active at: Le Roseau, LE BOSQUET, LES COCCINELLES, BETAPLUS PHARMA, CUSL PATRIMOINE, Fondation Saint - Luc, UCLouvain Patrimoine
since 2019 · until 2029
Establishments
Establishment units
Physical locations of this company
Hippokrateslaan 10
1200 Sint-Lambrechts-Woluwe
Emmanuel Mounierlaan 18
1200 Sint-Lambrechts-Woluwe
Active since 1 April 2024
Lenneke Marelaan 4
1932 Zaventem
Active since 1 November 2014
Neerveldstraat 109
1200 Sint-Lambrechts-Woluwe
Active since 1 January 2023
Emmanuel Mounierlaan 34
1200 Sint-Lambrechts-Woluwe
Active since 1 June 2025
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 33 companies are registered at this address.
All companies at this address →Societe Belge d'Urologie
€ 13,934 gross margin · 2023
Coeur, Sport et Santé
Association belge de Médecine nucléaire - belgische Vereniging voor Nucleaire Geneeskunde
Enfance et Cerveau - Het Kind en het Zenuwstelsel
Association du Personnel des Cliniques universitaires Saint-Luc
+28 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0416.885.016
- VAT number
- BE 0416.885.016
- Registered office
- Hippokrateslaan 10, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- Cliniques universitaires Saint-Luc
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 13 October 1976
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van algemene ziekenhuizen, muv geriatrische en gespecialiseerde ziekenhuizen
Ziekenhuizen
Activiteiten van medisch specialisten